Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in Treatment
Primary central nervous system lymphoma (PCNSL) is a group of extranodal non-Hodgkin lymphoma that exhibits specific biological characteristics and clinical behavior, with an aggressive disease course and unsatisfactory patient outcomes. It is of great importance to identify aberrant genetic loci an...
Main Authors: | Qingqing Cai, Yu Fang, Ken H. Young |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-03-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523318305941 |
Similar Items
-
Primary central nervous system lymphoma: status and advances in diagnosis, molecular pathogenesis, and treatment
by: Yan Zhang, et al.
Published: (2020-06-01) -
Advances in Pathobiology of Primary Central Nervous System Lymphoma
by: Xue-Liang Yang, et al.
Published: (2017-01-01) -
Treatment of primary central nervous system lymphomas
by: I. V. Cherkashina, et al.
Published: (2021-06-01) -
Relapsed Primary Central Nervous System Lymphoma: Current Advances
by: Kaiyan Tao, et al.
Published: (2021-04-01) -
Primary central nervous system lymphoma
by: Sarah Löw, et al.
Published: (2018-10-01)